SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Unquoted Biotechs

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who started this subject9/14/2001 3:52:07 PM
From: scaram(o)uche  Read Replies (1) of 253
 
re. Medinox.......

Neurology 2001 Sep 11;57(5):892-894

Cooling garment treatment in MS: Clinical improvement and decrease in
leukocyte NO production.

Beenakker EA, Oparina TI, Hartgring A, Teelken A, Arutjunyan AV, De Keyser J.

Department of Neurology (Drs. Beenakker, Teelken, and De Keyser, and A. Hartgring),
Academisch Ziekenhuis Groningen, The Netherlands.

Ten heat-sensitive patients with MS were randomly allocated in a cross-over study to wear a
cooling garment for 60 minutes at 7 degrees C (active cooling) and 26 degrees C (sham cooling).
In contrast to sham cooling, active cooling improved fatigue and postural stability with eyes
closed and muscle strength. There was no decrease in tympanic temperature, but active cooling
was associated with a 41% decrease in mean leukocyte nitric oxide (NO) production (p =
0.004). This effect on NO could be relevant because it blocks conduction in demyelinated axons.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext